34,395,238Related party -75,584Total sales 47,227,46134,470,822Cost of sales External customers 15,715,7279,277,204Related party -34,394Cost of sales 15,715,7279,311,598Gross profit 31,511,73425,159,224Operating expenses Selling expenses 4,826,1072,449,913General and administrative expenses 7,145,7947,464,141Research and development expenses 710,588710,991Income from operations 18,829,24514,534,179Other (income) / expenses Equity in income of an equity method investee (1,022,412)(270,394)Change in fair value of derivative liabilities (1,209,382)(1,021,865)Interest expense 608,5631,680,922Interest income (543,395)(170,131)Other expenses, net 100,989224,231Total other (income) / expenses, net (2,065,637)442,763Earnings before income tax expense 20,894,88214,091,416Income tax expense 3,176,7154,263,216Net income 17,718,1679,828,200Less: Net income attributable to the noncontrolling interest 4,760,8613,519,225Net income attributable to China Biologic Products, Inc. 12,957,3066,308,975Earnings per share: Basic
0.23Weighted average shares used in computation: Basic 25,601,12524,351,125Diluted 26,547,88525,680,648Other Comprehensive income, net of nil income taxes Foreign currency translation adjustment 1,176,9571,126,414Comprehensive income 18,895,12410,954,614Less: Comprehensive income attributable to the noncontrolling interest 5,015,8353,787,831Comprehensive income attributable to China Biologic Products, Inc.
CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETSMarch 31, December 31, 20122011ASSETS Current Assets Cash
89,411,835Accounts receivable, net of allowance for doubtful accounts 24,744,94916,757,368Inventories 70,584,06971,338,590Other receivables 2,583
|SOURCE China Biologic Products, Inc.|
Copyright©2010 PR Newswire.
All rights reserved